Skip to content

Prospective Analysis of Intraoperative AMNIOGEN® Injection in Patients With Rotator Cuff Tear

Prospective Analysis of Intraoperative AMNIOGEN® Injection in Patients With Rotator Cuff Tear

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04599673
Enrollment
100
Registered
2020-10-23
Start date
2020-10-15
Completion date
2022-09-30
Last updated
2020-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Tears

Brief summary

Purpose: The purpose of this article is to examine the clinical application of AMNIOGEN® in patients with rotator cuff tear. Methods: The study was conducted on 100 adult participants with age over affected by unilateral shoulder rotator cuff tear and receiving RCT repair. The investigators divided the participants in two groups, and the group A was treated with perioperative injection of AMNIOGEN® A, group B with perioperative normal saline. Follow-up: Every 1,3,and 12months, the investigators recheck physical exmianation at OPD and recheck MRI at postoperative 3 months.

Interventions

DRUGAMNIOGEN

AmnioGen® amnion matrix allograft is a bioactive tissue matrix processed from 100% human amniotic tissue. The allograft is processed with advanced technology so the graft can be suspended in liquids and applied through needles and syringes. Amniotic tissue is composed of structural extracellular matrix, which is rich in various types of collagen, growth factors, cytokines, and specialized proteins. Thus, the application of amniotic tissue is known to modulate localized tissue inflammation, reduce scar tissue formation and promote the healing of soft tissue.

OTHERnormal saline

10 ml normal saline

Sponsors

Kaohsiung Veterans General Hospital.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* receiving unilateral shoulder RCT repair in our hospital postoperative follow-up over 3 month

Exclusion criteria

* postoperative follow-up less than 3 month possible pregnency with coagulation disease NSAIDs intake during study period

Design outcomes

Primary

MeasureTime frameDescription
100 of participants with preoperative and postoperative physical examination are accessed by Empty can testpostoperative 1 monththe investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist
100 of participants with preoperative and postoperative Magnetic Resonance Imaging are accessedpostoperative 3 monthsize and site of rotator cuff tear was accessed by MRI T1 and T2 image; MRI was checked by one orthopedist

Countries

Taiwan

Contacts

Primary ContactYi Ping Wei, MD
xgoznas22@gmail.com+886-7-342-2121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026